These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 7537607)
21. Measurement of CD34+ cells in bone marrow by flow cytometry. Trischmann TM; Schepers KG; Civin CI J Hematother; 1993; 2(3):305-13. PubMed ID: 7522885 [TBL] [Abstract][Full Text] [Related]
22. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells. McCowage GB; Phillips KL; Gentry TL; Hull S; Kurtzberg J; Gilboa E; Smith C Exp Hematol; 1998 Apr; 26(4):288-98. PubMed ID: 9546311 [TBL] [Abstract][Full Text] [Related]
23. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234 [TBL] [Abstract][Full Text] [Related]
24. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857 [TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells. Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089 [TBL] [Abstract][Full Text] [Related]
26. [Quantitative flow-cytometric analysis of CD34-positive stem cells in peripheral blood stem cell harvests]. Morii T; Nishikawa K; Shimoyama T; Yamanaka T; Matsumoto M; Yagi H; Samma S; Fujimura Y; Yoshioka A; Narita N Rinsho Ketsueki; 1994 Jul; 35(7):649-56. PubMed ID: 7520511 [TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting. Kato K; Radbruch A Cytometry; 1993; 14(4):384-92. PubMed ID: 7685679 [TBL] [Abstract][Full Text] [Related]
28. Combined measurement of growth and differentiation in suspension cultures of purified human CD34-positive cells enables a detailed analysis of myelopoiesis. Kerst JM; Slaper-Cortenbach IC; von dem Borne AE; van der Schoot CE; van Oers RH Exp Hematol; 1992 Nov; 20(10):1188-93. PubMed ID: 1385196 [TBL] [Abstract][Full Text] [Related]
29. Use of large polygonal contiguous gates for flow cytometry analysis of circulating progenitor cells. Buscemi F; Fabbiano F; Felice R; DiNoto R; Cappuzzo V; Majolino I; Caronia F Bone Marrow Transplant; 1993 Sep; 12(3):305-6. PubMed ID: 7694725 [No Abstract] [Full Text] [Related]
30. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus. Lardon F; Snoeck HW; Nijs G; Lenjou M; Peetermans ME; Rodrigus I; Berneman ZN; Van Bockstaele DR Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393 [TBL] [Abstract][Full Text] [Related]
31. The CD34 molecule and hematopoietic progenitor cell studies--a challenge in clinical medicine. Egeland T Vox Sang; 1998; 74 Suppl 2():467-8. PubMed ID: 9704483 [TBL] [Abstract][Full Text] [Related]
32. c-kit ligand combined with GM-CSF and/or IL-3 can expand CD34+ hematopoietic progenitor subsets for several weeks in vitro. Steen R; Mørkrid L; Tjønnfjord GE; Egeland T Stem Cells; 1994 Mar; 12(2):214-24. PubMed ID: 7515297 [TBL] [Abstract][Full Text] [Related]
33. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. Brandt J; Srour EF; van Besien K; Briddell RA; Hoffman R J Clin Invest; 1990 Sep; 86(3):932-41. PubMed ID: 1697607 [TBL] [Abstract][Full Text] [Related]
34. [Flow cytometry identification of CD34-positive cells]. Tichelli A; Kralj A; Huxol H; Schönenberger A; Rabaglio M; Borel J; Müller R; Bargetzi M; Gratwohl A; Signer E Schweiz Med Wochenschr; 1995 Mar; 125(9):400-4. PubMed ID: 7534431 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. Steen R; Tjønnfjord GE; Egeland T J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606 [TBL] [Abstract][Full Text] [Related]
36. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression. Rumi C; Rutella S; Teofili L; Etuk B; Ortu La Barbera E; Micciulli G; Voso MT; Leone G Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301 [TBL] [Abstract][Full Text] [Related]
38. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells. Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217 [TBL] [Abstract][Full Text] [Related]
39. Change in FAS antigen expression during differentiation of CD34-positive cells isolated from peripheral blood stem cell harvest samples. Yamane T; Hino M; Tatsumi N Eur J Haematol; 1997 Apr; 58(4):289-90. PubMed ID: 9186542 [No Abstract] [Full Text] [Related]